Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
American Journal of Clinical Oncology
|
October 1, 1987
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study
R M Bukowski, A Theodors, J D Purvis, et al.
Journal of Cancer Research and Clinical Oncology
|
September 10, 1999
Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer
G T Budd, J Atiba, R T Silver, et al.
Urology
|
October 6, 2000
Leiomyosarcoma of the main renal artery treated by laparoscopic radical nephrectomy
I S Gill, M G Hobart, J H Kaouk, et al.
Investigational New Drugs
|
June 9, 1999
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
K Rajagopalan, D Peereboom, G T Budd, et al.
Cancer
|
October 15, 1991
A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer
G T Budd, S Green, L H Baker, et al.
Cancer
|
February 15, 1990
High-dose cisplatin for metastatic soft tissue sarcoma
G T Budd, B Metch, S P Balcerzak, et al.
Cancer
|
February 1, 1997
Pelvic computed tomography of breast carcinoma patients. Should it routinely be added to abdominal computed tomography?
J I Meyer, B R Herts, D M Einstein, et al.
Oncogene
|
December 1, 2009
Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer
S Kulkarni, K B Reddy, F J Esteva, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 1, 1994
Amifostine: potential for clinically useful cytoprotection
G T Budd, V Lorenzi, R Ganapathi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study
G T Budd, B Metch, S A Weiss, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
American Journal of Clinical Oncology
|
October 1, 1987
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study
R M Bukowski, A Theodors, J D Purvis, et al.
Journal of Cancer Research and Clinical Oncology
|
September 10, 1999
Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer
G T Budd, J Atiba, R T Silver, et al.
Urology
|
October 6, 2000
Leiomyosarcoma of the main renal artery treated by laparoscopic radical nephrectomy
I S Gill, M G Hobart, J H Kaouk, et al.
Investigational New Drugs
|
June 9, 1999
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
K Rajagopalan, D Peereboom, G T Budd, et al.
Cancer
|
October 15, 1991
A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer
G T Budd, S Green, L H Baker, et al.
Cancer
|
February 15, 1990
High-dose cisplatin for metastatic soft tissue sarcoma
G T Budd, B Metch, S P Balcerzak, et al.
Cancer
|
February 1, 1997
Pelvic computed tomography of breast carcinoma patients. Should it routinely be added to abdominal computed tomography?
J I Meyer, B R Herts, D M Einstein, et al.
Oncogene
|
December 1, 2009
Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer
S Kulkarni, K B Reddy, F J Esteva, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 1, 1994
Amifostine: potential for clinically useful cytoprotection
G T Budd, V Lorenzi, R Ganapathi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study
G T Budd, B Metch, S A Weiss, et al.
Page
of 7